Kovacs P, Ma L, Hanson R L, Franks P, Stumvoll M, Bogardus C, Baier L J
Medical Department III, University of Leipzig, Germany.
Diabetologia. 2005 Nov;48(11):2292-5. doi: 10.1007/s00125-005-1934-9. Epub 2005 Sep 16.
AIMS/HYPOTHESIS: Uncoupling protein-2 (UCP2) is thought to play a role in insulin secretion and the development of obesity. In this study, we investigated the effects of genetic variation in UCP2 on type 2 diabetes and obesity, as well as on metabolic phenotypes related to these diseases, in Pima Indians.
The coding and untranslated regions of UCP2, and approximately 1 kb of the 5' upstream region, were sequenced in DNA samples taken from 83 extremely obese Pima Indians who were not first-degree relatives.
Five variants were identified: (1) a -866G/A in the 5' upstream region; (2) a G/A in exon 2; (3) a C/T resulting in an Ala55Val substitution in exon 4; and (4, 5) two insertion/deletions (ins/del; 45-bp and 3-bp) in the 3' untranslated region. Among the 83 subjects whose DNA was sequenced, the -866G/A was in complete genotypic concordance with the Ala55Val and the 3-bp ins/del polymorphism. The G/A polymorphism in exon 2 was extremely rare. To capture the common variation in this gene for association analyses, the -866G/A variant (as a representative of Ala55Val and the 3-bp ins/del polymorphism) and the 45-bp ins/del were also genotyped for 864 full-blooded Pima Indians. Neither of these variants was associated with type 2 diabetes or body mass index. However, in a subgroup of 185 subjects who had undergone detailed metabolic measurements, these variants were associated with 24-h energy expenditure as measured in a human metabolic chamber (p=0.007 for the 45-bp ins/del and p=0.03 for the -866G/A after adjusting for age, sex, family membership, fat-free mass and fat mass).
CONCLUSIONS/INTERPRETATION: Our data indicate that variation in UCP2 may play a role in energy metabolism, but this gene does not contribute significantly to the aetiology of type 2 diabetes and/or obesity in Pima Indians.
目的/假设:解偶联蛋白2(UCP2)被认为在胰岛素分泌和肥胖症的发生发展中起作用。在本研究中,我们调查了UCP2基因变异对皮马印第安人2型糖尿病、肥胖症以及与这些疾病相关的代谢表型的影响。
对从83名非一级亲属的极度肥胖皮马印第安人采集的DNA样本中UCP2的编码区、非翻译区以及约1 kb的5'上游区域进行测序。
鉴定出5种变异:(1)5'上游区域的-866G/A;(2)外显子2中的G/A;(3)外显子4中导致Ala55Val替换的C/T;以及(4、5)3'非翻译区的两个插入/缺失(插入/缺失;45 bp和3 bp)。在测序的83名受试者中,-866G/A与Ala55Val和3 bp插入/缺失多态性完全基因型一致。外显子2中的G/A多态性极其罕见。为了捕获该基因的常见变异用于关联分析,还对864名纯种皮马印第安人进行了-866G/A变异(作为Ala55Val和3 bp插入/缺失多态性的代表)和45 bp插入/缺失的基因分型。这些变异均与2型糖尿病或体重指数无关。然而,在185名进行了详细代谢测量的受试者亚组中,这些变异与在人体代谢室中测量的24小时能量消耗相关(调整年龄、性别、家族成员、去脂体重和脂肪量后,45 bp插入/缺失的p = 0.007,-866G/A的p = 0.03)。
结论/解读:我们的数据表明,UCP2的变异可能在能量代谢中起作用,但该基因对皮马印第安人2型糖尿病和/或肥胖症的病因学贡献不大。